Advertisement
Screener

CULLINAN THERAPEUTICS, INC. (CGEM) ROA

CULLINAN THERAPEUTICS, INC. (CGEM) ROA

  • 2026-06-30: ROA -56.27%.
  • 2026-03-31: ROA -54.85%.
  • 2025-12-31: ROA -49.04%.
  • 2025-09-30: ROA -44.78%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-56.27%
2026-03-31-54.85%
2025-12-31-49.04%
2025-09-30-44.78%
2025-06-30-39.74%
2025-03-31-30.83%
2024-12-31-26.92%
2024-09-30-21.97%
2024-06-30-20.87%
2024-03-31-29.45%
2023-12-31-31.63%
2023-09-30-31.56%
2023-06-30-27.16%
2023-03-3112.69%
2022-12-3119.82%
2022-09-3017.09%
2022-06-3016.93%
2022-03-31-17.74%
2021-12-31-15.00%
2021-09-30-13.54%
2021-06-30-11.61%
2021-03-31-9.78%
2020-12-31-24.13%

Annual ROA

DateROA
2025-12-31-49.04%
2024-12-31-26.92%
2023-12-31-31.63%
2022-12-3119.82%
2021-12-31-15.00%
2020-12-31-24.13%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Replimune Group, Inc. (REPL)United States$1.186B-3.13
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10